InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Rotem-Wildeman Karin. Director active across 1 company, notably Keurig Dr Pepper Inc.. In total, 5 disclosures have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €1.2m. Activity tracked since 14 March 2023. The latest transaction was disclosed on 7 March 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Karin Rotem-Wildeman is a declarant linked to Keurig Dr Pepper Inc. (XNAS), where the listed role is Chief R&D Officer. She has 5 filings in total, and the 5 sampled filings, between 2023-03-16 and 2024-03-11, show acquisitions for EUR 1170414 and no sales.